MAR-Cetirizine: Impurity
Last updated
Summary
Product
MAR-Cetirizine
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| MAR-Cetirizine | MAR-Cetirizine 10mg | DIN 02427133 | Tablet | Cetirizine Hydrochloride 10 mg | MC19002, MC19003 |
| MAR-Cetirizine | MAR-Cetirizine 20mg | DIN 02427141 | Tablet | Cetirizine Hydrochloride 20 mg | MC-20004, MC-20005A |
Issue
| The impurities are out of specification in the affected lots. |
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of Recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
|
Marcan Pharmaceuticals Inc. 2 Gurdwara Road, Suite #112, Ottawa, Ontario, K2E 1A2 |
Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type II
Identification number
RA-63566
Get notified
Receive emails about new and updated recall and safety alerts.